i
Cost-effectiveness analysis of BOOSTRIX® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) among Individuals≥ 65 years of age in prevention of Pertussis
-
February 22, 2012
Series: ACIP meeting Pertussis Vaccines
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subject:
-
Series:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +